Log in to save to my catalogue

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7155173

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency

About this item

Full title

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2020-01, Vol.382 (3), p.256-265

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

A neonate with a loss-of-function mutation in
USP18
and exuberant expression of interferon-stimulated genes was experimentally treated with ruxolitinib, which suppresses interferon signaling. The initiation of treatment was followed by an improvement in the child’s clinical course.

Alternative Titles

Full title

JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7155173

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7155173

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1905633

How to access this item